Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages
Tóm tắt
Từ khóa
Tài liệu tham khảo
Petersen PE (2009) Oral cancer prevention and control—the approach of the world health organization. Oral Oncol 45(4–5):454–460
Altieri A et al (2002) Cessation of smoking and drinking and the risk of laryngeal cancer. Br J Cancer 87(11):1227–1229
Balaram P et al (2002) Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 98(3):440–445
Ang KK et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35
Mirghani H et al (2015) Increased radiosensitivity of HPV-positive head and neck cancers: molecular basis and therapeutic perspectives. Cancer Treat Rev 41(10):844–852
Prasanna A et al (2014) Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy. J Thorac Dis 6(4):287–302
Gaipl US et al (2014) Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy. Immunotherapy 6(5):597–610
Gameiro SR et al (2014) Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T‑cell killing. Oncotarget 5(2):403–416
Derer A et al (2016) Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors. Cancer Immunol Immunother 65(7):779–786
Manukian G et al (2019) Combining radiation and immune checkpoint blockade in the treatment of head and neck squamous cell carcinoma. Front Oncol 9:122
Miyauchi S et al (2019) Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics. Clin Cancer Res 25(14):4211–4223
Spiotto M, Fu YX, Weichselbaum RR (2016) The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications. Sci Immunol 1(3):EAAG1266. https://doi.org/10.1126/sciimmunol.aag1266
Watanabe Y et al (2010) Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109(5):744–752
Shah W et al (2011) A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell Mol Immunol 8(1):59–66
Ino Y et al (2013) Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 108(4):914–923
Kurahara H et al (2011) Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 167(2):e211–9
Ou D et al (2019) Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy. Radiother Oncol 130:89–96
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423–1437
Zhang X et al (2020) Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas. Strahlenther Onkol 196(10):913–921
Mantovani A et al (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399–416
Yang Y et al (2014) M‑CSF cooperating with NFkappaB induces macrophage transformation from M1 to M2 by upregulating c‑Jun. Cancer Biol Ther 15(1):99–107
Hood JL (2016) Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes. Med Hypotheses 94:118–122
Duits DEM, Wellenstein MD, de Visser KE (2020) In vitro assessment of cancer cell-induced polarization of macrophages. Methods Enzymol 632:133–154
Italiani P, Boraschi D (2014) From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 5:514
Mantovani A, Sica A, Locati M (2007) New vistas on macrophage differentiation and activation. Eur J Immunol 37(1):14–16
Mantovani A et al (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229(2):176–185
Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122(3):787–795
Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39–51
De Palma M, Lewis CE (2013) Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23(3):277–286
Mantovani A et al (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol 70(5):325–330
Abumaree MH et al (2013) Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages. Stem Cell Rev Rep 9(5):620–641
Chylikova J et al (2018) M1/M2 macrophage polarization in human obese adipose tissue. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 162(2):79–82
de Gaetano M et al (2016) M1- and M2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis. Front Immunol 7:275
Barros MH et al (2013) Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS ONE 8(11):e80908
Martinez FO et al (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177(10):7303–7311
Ambarus CA et al (2012) Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods 375(1–2):196–206
Mantovani A et al (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555
de Villiers WJ et al (1994) Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J Exp Med 180(2):705–709
Mia S et al (2014) An optimized protocol for human M2 macrophages using M‑CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand J Immunol 79(5):305–314
Lau SK, Chu PG, Weiss LM (2004) CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 122(5):794–801
Stein M et al (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176(1):287–292
Law SK et al (1993) A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur J Immunol 23(9):2320–2325
Kittan NA et al (2013) Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS ONE 8(10):e78045
Weber M et al (2014) Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages—an immunohistochemical analysis. J Craniomaxillofac Surg 42(7):1087–1094
Hirata Y et al (2011) Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 58(3):248–255
Cao X et al (2011) Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int 61(9):528–535
Murray PJ, Wynn TA (2011) Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 89(4):557–563
Lan C et al (2013) Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat 12(3):259–267
Hao NB et al (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012:948098
Mantovani A et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677–686
Porcheray F et al (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142(3):481–489
Bardi GT, Smith MA, Hood JL (2018) Melanoma exosomes promote mixed M1 and M2 macrophage polarization. Cytokine 105:63–72
Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66(2):605–612
Ozcan-Wahlbrink M, Schifflers C, Riemer AB (2019) Enhanced radiation sensitivity of human papillomavirus-driven head and neck cancer: focus on immunological aspects. Front Immunol 10:2831
Ruffell B, Affara NI, Coussens LM (2012) Differential macrophage programming in the tumor microenvironment. Trends Immunol 33(3):119–126
Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253–268
Sica A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42(6):717–727
Petruzzi MN et al (2017) Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge. Diagn Pathol 12(1):32
Lecoultre M, Dutoit V, Walker PR (2020) Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. J Immunother Cancer 8(2):e1408. https://doi.org/10.1136/jitc-2020-001408
DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19(6):369–382
Feng M et al (2019) Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat Rev Cancer 19(10):568–586
Chao MP, Weissman IL, Majeti R (2012) The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol 24(2):225–232
Gordon SR et al (2017) PD‑1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545(7655):495–499
Okubo M et al (2016) M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation. Sci Rep 6:27548
Chiang CS et al (2012) Irradiation promotes an m2 macrophage phenotype in tumor hypoxia. Front Oncol 2:89
Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196(3):254–265
Sedghizadeh PP et al (2016) Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis. Oral Oncol 54:15–27
Cleary C et al (2016) Biological features of human papillomavirus-related head and neck cancers contributing to improved response. Clin Oncol (R Coll Radiol) 28(7):467–474
Dave E et al (2017) The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer. PLoS ONE 12(7):e181108
O’Sullivan B et al (2012) Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol 103(1):49–56
Rodel F et al (2019) Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy. Biochim Biophys Acta Rev Cancer 1871(1):126–137
Bronte V, Murray PJ (2015) Understanding local macrophage phenotypes in disease: modulating macrophage function to treat cancer. Nat Med 21(2):117–119
Taberna M et al (2017) Human papillomavirus-related oropharyngeal cancer. Ann Oncol 28(10):2386–2398
Chaturvedi AK et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301
Rieckmann T et al (2013) HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol 107(2):242–246
Kimple RJ et al (2013) Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res 73(15):4791–4800
Gaipl US et al (2001) Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 8(4):327–334
Ravichandran KS (2011) Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35(4):445–455
Garg AD et al (2010) Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 1805(1):53–71
Zitvogel L, Kepp O, Kroemer G (2010) Decoding cell death signals in inflammation and immunity. Cell 140(6):798–804
Chao MP et al (2010) Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2(63):63ra94
Gardner M et al (2020) In vitro macrophage-mediated phagocytosis assay of brain tumors. Cureus 12(10):e10964
Hanoteau A et al (2019) Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. J Immunother Cancer 7(1):10
Bondanza A et al (2004) Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 200(9):1157–1165
Fujii N et al (2012) Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance. J Oral Pathol Med 41(6):444–451
Russell S et al (2013) Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol 5(3):24
Weber M et al (2016) Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas. Oral Oncol 52:75–84
Shapouri-Moghaddam A et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425–6440
Lee S et al (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22(2):317–326
Stout RD, Suttles J (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76(3):509–513
Duluc D et al (2009) Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 125(2):367–373
Hagemann T et al (2008) “Re-educating” tumor-associated macrophages by targeting NF-kappaB. J Exp Med 205(6):1261–1268
Dong H et al (2020) Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype. J Immunother Cancer 8(1):e339
Kawamura K et al (2009) Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 59(5):300–305
She L et al (2018) Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck. Cancer Cell Int 18:120